Vaccine

(Daniel Paquet/Flickr)

Indiana health officials say they hope to make a COVID-19 vaccine available to every health care worker and nursing home resident in the state by the end of December.

Photo provided by the State of Michigan

Governor Gretchen Whitmer acknowledged Tuesday that it’s becoming more difficult to get people to follow mask, distance, and gathering guidelines to slow the spread of COVID-19. That’s as her top health advisor warned that a new wave of infections is likely following Thanksgiving gatherings.

(Courtesy of Johnson & Johnson)

In the wake of promising vaccine trials and still-surging COVID-19 cases, the phrase “herd immunity” has entered the popular vocabulary. 

It refers to the idea that if enough people in a community are exposed to a virus, it will eventually die out. It’s a real phenomenon, but it’s not possible without some sort of intervention.

Elkhart County Health Officer Lydia Mertz said it would take over five years to achieve herd immunity in Elkhart County without a vaccine – and that’s with every resource in every hospital dedicated to caring for coronavirus patients.

CHIP SOMODEVILLA / GETTY IMAGES

President Trump is expected to give an update on the coronavirus pandemic at 4pm. He will be speaking for the first time since Joe Biden became president-elect. Trump has been falsely claiming on Twitter that he won, and his campaign launched a slew of lawsuits challenging the legitimacy of the results and baselessly alleging widespread voter fraud. Watch his remarks live.

(Courtesy of Johnson & Johnson)

Johnson & Johnson has resumed its COVID-19 vaccine trial in northwest Indiana nearly a month after the company paused the study. In northwest Indiana, the study is being coordinated through Buynak Clinical Research in Valparaiso. The clinic is currently looking for participants for the trial. 

Pfizer Says Early Data Signals COVID-19 Vaccine May Be 90% Effective

Nov 9, 2020
AP

Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19. Monday's announcement doesn't mean a vaccine is imminent. The interim analysis, from independent data monitors, looked at 94 infections recorded so far in a study that has enrolled nearly 44,000 people. Pfizer did not provide any more details about those cases, and cautioned the initial protection rate might change by the time the study ends. The shots are made by Pfizer and its German partner BioNTech. Pfizer has said it plans to seek U.S. review later this month.

 

(Justin Hicks/IPB News)

Indiana’s State Health Commissioner says a COVID-19 vaccine could be available for some Hoosiers as early as mid to late November.

Study Pauses Are More Common, Essential To Clinical Trials

Oct 15, 2020
(Pixabay)

Eli Lilly paused trials of its COVID-19 treatment drug Tuesday. The news came less than a day after Johnson & Johnson also paused its trial on a COVID-19 vaccine.

(Justin Hicks/IPB News)

The Indiana State Department of Health reported 68 additional confirmed deaths over the last week, bringing the state’s total to 3,140. The state announced more than 99,000 total confirmed cases – including two days with more than 1,000 reported cases – and more than 1.5 million Hoosiers tested.

(AP Photo/Hans Pennink)

 

DETROIT (AP) — A hospital system in southeastern Michigan is looking for up to 5,000 volunteers for a COVID-19 vaccine study. Henry Ford Health System is working with the National Institutes of Health and Moderna Inc., which want 30,000 people in the U.S. Volunteers won’t know if they’re getting the real shot or a dummy version. After two doses, scientists will closely track which group experiences more infections as they go about their daily routines. People who want to volunteer or learn more about the vaccine trial can visit www.henryford.com/ModernaVaccine.  

IU Researcher Begins Work On Coronavirus Vaccine

Apr 6, 2020
Indiana University

Indiana University Associate Professor of Biology John Patton is modifying an existing vaccine that he hopes will become a vaccine for COVID-19.

Patton, and students in his lab are building on work they have done exploring the rotavirus. Rotavirus causes nausea and diarrhea in children, and its vaccine may work on coronavirus patients.

“Using genetic engineering technology to modify that vaccine,” Patton says.

Patton says he’s making viruses in his lab that will eventually become “vaccine candidates" for the coronavirus.

Some Hoosiers May Need Another MMR Shot

May 3, 2019
Lauren Chapman

This week the Indiana State Department of Health made it easier for anyone to get the measles, mumps and rubella, or MMR, vaccine, without a prescription.

Indiana’s relatively strict vaccination requirements could put the state at less risk of widespread outbreaks of vaccine-preventable illnesses.

Pages